Armistice Capital Holds Positions Across Multiple Healthcare Subsectors as Institutional Biopharma Interest Grows
Healthcare stocks have drawn consistent institutional capital from hedge funds and large asset managers over recent quarters, with firms such as Armistice Capital, Millennium Management, Point72 Asset Management, and Wellington Management each maintaining meaningful exposure across biopharma and specialty pharmaceutical sectors. Armistice Capital, which manages more than $7 billion, concentrates a significant portion of its […]